Currently funded projects

The role of microglia in the translational 5xFAD wildling mouse model of Alzheimer's disease
Institution: Institute of Neuropathology, University of Freiburg, University Hospital
Applicant: Daniel Erny
EKFS funding line: Else Kröner Excellence Fellowship

Influence of hormonal regulatory circuits on antitumor immune responses following radiation therapy
Institution: Department of Radiation Oncology, Technical University of Munich (TUM)
Applicant: Dr. Julius C. Fischer
EKFS funding line: Else Kröner Memorial Fellowships

Role, regulation and exploitation of Zinc finger Antiviral Protein and Regnase-1-like endonucleases in antiviral innate immunity
Institution: Ulm University Medical Center
Applicant: Dorota Kmiec
EKFS funding line: First and Second Applications

Advanced engineered organotypic models of fibrosis for pathophysiological studies and for testing novel therapeutic approaches
Institution: Clinic for Rheumatology and Hiller Research Center, University Hospital of Düsseldorf and Heinrich-Heine-University (HHU) Düsseldorf
Applicant: Dr. Alexandru-Emil Matei
EKFS funding line: Else Kröner Memorial Fellowships

Immunooncology and local interventions (IOLIN)
Institution: Klinikum der Ludwig-Maximilians-Universität München
Applicants: Prof. Dr. Sebastian Kobold (Speaker), Prof. Dr. Kirsten Lauber (deputy speaker), Prof. Dr. Dr. Michael von Bergwelt (deputy speaker)
EKFS funding line: Else Kröner Research School

iPRIME - Clinician Scientist
Institution: University Medical Center Hamburg-Eppendorf (UKE)
Applicants Prof. Dr. Tobias B. Huber (Speaker) , Prof. Dr. Ulf Panzer (Speaker)
EKFS funding line: Else Kröner Research School

Impact of antigen recognition and immunosuppression on pathogen-specific follicular T helper cells
Institution: Department of Internal Medicine II, University Hospital Freiburg
Applicant: Tobias Böttler
EKFS funding line: Else Kröner Excellence Fellowships

Harnessing tissue-specific chemokines for the recruitment of Natural Killer cells to liver cancer
Institution: Department of Medicine II, Klinikum rechts der Isar, Technical University of Munich
Applicant: PD Dr. Gabriela Wiedemann
EKFS funding line: First and Second Applications
Professorship of immunomodulation through targeted cell trafficking
Institution: Medicine 1, University Hospital Erlangen
Applicant: PD Dr. Dr. Sebastian Zundler
EKFS funding line: Clinician Scientist Professorship

Overcoming dysfunctional immune responses in chronic HPV/ HIV infection: a way to cure
Institution: Department of Infectious Diseases, Medizinische Klinik IV, LMU University Hospital
Applicants: PD Dr. Julia Roider
EKFS funding line: First and Second Applications